Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will virtually participate in the following investor conferences in August.
BTIG Biotechnology Conference 2022
Date: Tuesday, August 9, 2022
2022 Wedbush PacGrow Healthcare Virtual Conference
Date: Wednesday, August 10, 2022
Panel Discussion: 2:20 p.m. ET
A live webcast of the Wedbush panel discussion will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
VP, Investor Relations & Corp. Communications
Investor and Media Contact: